Wikidata

(Q43802386)

English

Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer

scientific article published in September 2003

In more languages

Statements

title
Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
author name string
Glenn Liu
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
Mary Jane Staab
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
Dorthea Horvath
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
Kelly Miller
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
Amy Dresen
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
Dona Alberti
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
Rhoda Arzoomanian
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
Rick Chappell
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
Howard H Bailey
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
publication date
1 September 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017
page(s)
4077-4083
1 reference
stated in
Europe PubMed Central
PubMed ID
14519629
retrieved
26 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43802386&oldid=2103466390"